September 13, 2021 6:44 PM
BEIJING (Bloomberg) – Chinese biopharma firm Everest Medicines will license an mRNA Covid-19 vaccine from Canada’s Providence Therapeutics Holdings as companies try to bring the most effective inoculation platform into China despite its apparent resistance to western shots.



